Patents by Inventor Teit Johansen

Teit Johansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250171562
    Abstract: Disclosed are single domain antibody-based constructs, which are useful for treating IgE-related disorders or conditions by facilitating the dissociation of IgE from the high-affinity IgE receptor. Further disclosed are compositions comprising the constructs.
    Type: Application
    Filed: June 30, 2023
    Publication date: May 29, 2025
    Applicants: ALK-Abelló, Aarhus Universitet
    Inventors: Edzard Spillner, Sivelle Coline, Lars Harder Christensen, Peter Sejer Andersen, Gitte Lund, Teit Johansen, Frederic Jabs, Anne-Sofie Ravn Ballegaard, Andrea Maria Kemter
  • Publication number: 20070275026
    Abstract: The present invention relates to the field of therapeutic use of proteins, genes and cells. More specifically the invention relates to therapy based on the biological function of a secreted therapeutic protein. NsG33, in particular for the treatment of disorders of the nervous system. NsG33 is a nerve survival and growth factor with antiapoptotic effects on a cell line with neuronal potential and with neuroprotective and/or neurogenesis effects on a neural precursor cell line and on primary striatal cultures. The invention also relates to novel bioactive NsG33 polypeptide fragments and the corresponding encoding DNA sequences.
    Type: Application
    Filed: March 30, 2005
    Publication date: November 29, 2007
    Applicant: NSGENE A/S
    Inventors: Mette Gronborg, Philip Kusk, Nikolaj Blom, Thomas Petersen, Teit Johansen, Soren Brunak, Lars Wahlberg
  • Publication number: 20070099270
    Abstract: The invention relates to neublastin neurotrophic factor polypeptides, nucleic acids encoding neublastin polypeptides, and antibodies that bind specifically to neublastin polypeptides, as well as methods of making and methods of using the same.
    Type: Application
    Filed: December 21, 2006
    Publication date: May 3, 2007
    Applicants: BIOGEN IDEC MA INC., NSGENE A/S
    Inventors: Dinah Sah, Teit Johansen, Anthony Rossomando
  • Publication number: 20040259779
    Abstract: The present invention relates to novel biologically active, processed forms of the neuronal survival and growth factor protein denominated NSG3, in particular the pro-protein, the mature protein and core fragment of NSG3, as well as variants thereof. Also, the use of the novel polypeptides for treating or preventing a neurodegenerative disease, in particular an excitotoxic disease, a cancer, tissue injury, insufficient bone cartilage growth and maturation or a disease involving muscle in an animal is described.
    Type: Application
    Filed: July 23, 2004
    Publication date: December 23, 2004
    Inventors: Teit Johansen, Nikolaj Blom, Claus Hansen